Agnès Gouble

Agnès Gouble has a diverse work experience across various companies and roles. Starting in 1997, they worked as an intern at Pierre Fabre. Agnès then pursued a PhD at Centre de Biologie du Développement CNRS from 1997 to 2001. Following that, they worked as a post-doctoral researcher at CIML in 2001-2002. Agnès joined Cellectis in 2002 as a Project Leader in the R&D department, focusing on genome engineering tools. Agnès became an R&D team manager at Cellectis Therapeutics in 2007 and continued in various roles within Cellectis until 2012, including Preclinical Director and Scientific Alliance Manager. In 2018, they were promoted to SVP Preclinical at Cellectis. Most recently, in 2022, Agnès joined Coave Therapeutics as the VP Program Management. Agnès has expertise in molecular biology, cellular biology, in vivo proof of concept, scientific program management, and establishment of scientific partnerships.

Agnès Gouble completed their Master of Engineering (M.Eng.) in Biotechnology from INSA Toulouse, France, from 1994 to 1997. Agnès then pursued a PhD in Molecular and Cellular Biology from the University of Toulouse, France. No specific start and end dates were provided for their PhD.